OpenVSafe by OpenVAERS
Search V-safe

WYM-13939-08542

3 vaccinations 1 coded response 7 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
089 / NJ
Registered
2021-09-04
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino
Registered dependents
DW5-22513-30082 Child or adolescent in my care · Male · 2021-09-04
45J-25764-45684 Child or adolescent in my care · Female · 2021-09-04
SDH-38691-61399 Child or adolescent in my care · Female · 2021-09-04

Timeline

  1. 2021-02-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  3. 2021-08-31
    Dose 3 — Pfizer-BioNTech
  4. 2021-09-04
    Registered in v-safe
  5. 2021-09-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-09-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  7. 2021-09-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  8. 2021-09-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  9. 2021-09-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  10. 2021-10-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  11. 2021-11-30
    Survey response — 3 months, dose 3
    MedDRA: No adverse event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: N/a
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-11-30
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2021-12-01
  14. 2021-12-06

Vaccinations

DoseDateManufacturerCo-administered
12021-02-08Pfizer-BioNTech No
22021-03-01Pfizer-BioNTech No
32021-08-31Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-11-30 Unsuccessful

Free text

Release 10 — 3 months, dose 3

2021-11-30

Symptoms: N/a

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNo adverse event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release